A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim efficacy data from the Phase I stage of its ...

A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac ...

FSR is dedicated to accelerating sarcoidosis research through its fellowships, pilot and cardiac grants, and other ...

NESS ZIONA, ISRAEL / ACCESSWIRE / November 26, 2024 / Enlivex Therapeutics Ltd. (Nasdaq:ENLV)(the "Company"), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite ...

In a study published in Cell Reports Physical Science on Nov. 25, a research team reported the development of an innovative ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the“Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Company's Board of Directors approved the purchase of ...

UC Santa Barbara's Meghan Morrissey is among those pioneering a new kind of immunotherapy, and her efforts have earned her ...

A research team led by NARO has successfully developed an immortalized red river hog blood-derived macrophage cell line.

Designed to treat end-stage liver disease, the company has been granted permission from the Spanish authorities to expand its ...

A research team led by NARO has successfully developed an immortalized red river hog blood-derived macrophage cell line.